Greetings friends and advisors, The reason we are revisiting the CMS/RIT issue is there's a rumor circulating that certain influential people and groups, and...
BMJ 2008;336:235 (2 February), doi:10.1136/bmj.39475.397338.DB NIH needs to raise oversight of conflicts of interest among researchers, report says Janice...
Surprised that current leadership at NCI should object ... tis the foundation of the review process and ought to be accounted for in all aspects of research...
[A newsy report on a paper published in Blood] Genesis of adult leukemia mapped 01.02.2008 - (idw) Schwedischer Forschungsrat - The Swedish Research Council ...
NEW STUDY CLARIFIES ROLE OF ANTIOXIDANTS DURING RADIATION TREATMENT An important paper on the interaction of antioxidants and radiation therapy was recently...
MUM1/IRF4 expression in the circulating compartment of chronic lymphocytic leukemia. F Craig, L Soma, M Melan, J Kant, and S Swerdlow Leuk Lymphoma, February...
Mycobacterium avium Complex Infection After Alemtuzumab Therapy for Chronic Lymphocytic Leukemia. CE Saadeh and G Srkalovic Pharmacotherapy, February 1, 2008;...
Negative selection of chronic lymphocytic leukaemia cells using a bifunctional rosette-based antibody cocktail. Salim Essakali, Dennis A Carney, David A...
The NF-{kappa}B subunit, Rel A, is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukaemia and represents a...
Cancer. 2008 Jan 25 [Epub ahead of print] Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic...
Immunomedics Announces First Patient Dosing of Veltuzumab, Resulting in a Complete Response, in Immune Thrombocytopenic Purpura February 04, 2008: 12:16 PM EST...
Genesis of adult leukemia mapped 01.02.2008 - (idw) Schwedischer Forschungsrat - The Swedish Research Council Long-term bacterial infections like pneumonia can...
You forgot one:) http://www.ontheissues.org/2008/Ron_Paul_Health_Care.htm ... From: <KarlS@...>...
tupperengland@...
Feb 5, 2008 11:44 pm
10872
Top-Rated Hospitals Continue to Deliver Better Care 01.31.08, 12:00 AM ET THURSDAY, Jan. 31 (HealthDay News) -- Patients admitted to the top- rated hospitals...
Dr. Temple is an acknowledged leader in the FDA on policy. ROBERT J. TEMPLE, M.D. on compassionate use: http://www.fda.gov/ola/2001/compassionateuse0620.html ...
Motion sickness strikes after CLL chemotherapy V.K. Gadi, M.D., Ph.D. January 21, 2008 Question: I completed chemo (R-CHOP) last March and had a complete...
[ATG already has a place in CLL; it's used in allogenic stem cells transplants to deplete T cells and foster engrafting of the donor cells. This article seems...
Physical Sciences Win Out Over Biomedicine in 2009 Budget Proposal By Science staff ScienceNOW Daily News 4 February 2008 President George W. Bush today...
While the need for federal government funding for the physical sciences is indeed meritorious, we need to make sure at the same time medical research is not ...
[Personally, I'm very surprised this press release came out at this time. There are 12 patients in this trial, and here comes a report on the first six....
UCSD Research Team Identifies Novel Anti-Cancer Drug from the Sea February 11, 2008 By Debra Kain A collaborative team of researchers spearheaded by Dennis...
Scott I am surprised as well. I am not sure why Dr. Kipps sent this out, but on most clinical studies that give early press releases, the company is looking...
I found this report quite relevant though It's not clear what the implications are for CLLers. Andy New Discoveries On What Does And Doesn't Affect Immune...
Eloxatin®-Based Regimen Effective for Richter's Syndrome of Chronic Lymphocytic Leukemia (CLL) Researchers from the MD Anderson Cancer Center have reported...
Having problems with message search?
Fill out this form to ensure your group is one of the first to be migrated to the new message search system.
